IRIS
CUCINOTTA, Domenico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.681
NA - Nord America 11.924
AS - Asia 7.121
SA - Sud America 2.752
AF - Africa 241
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 36.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.709
RU - Federazione Russa 7.245
SG - Singapore 3.026
BR - Brasile 2.379
CN - Cina 2.112
IE - Irlanda 1.871
SE - Svezia 1.570
DE - Germania 964
HK - Hong Kong 729
UA - Ucraina 704
FR - Francia 586
IT - Italia 568
FI - Finlandia 448
VN - Vietnam 419
GB - Regno Unito 358
IN - India 205
AR - Argentina 125
CA - Canada 87
PL - Polonia 83
TR - Turchia 83
BD - Bangladesh 81
MX - Messico 79
IQ - Iraq 71
EC - Ecuador 65
ZA - Sudafrica 65
AT - Austria 51
BE - Belgio 50
MA - Marocco 47
VE - Venezuela 47
JP - Giappone 45
ID - Indonesia 44
NL - Olanda 39
CO - Colombia 38
UZ - Uzbekistan 37
PK - Pakistan 35
PY - Paraguay 31
ES - Italia 30
CI - Costa d'Avorio 28
KE - Kenya 28
IR - Iran 26
UY - Uruguay 26
TN - Tunisia 22
JO - Giordania 20
AZ - Azerbaigian 19
PE - Perù 18
CL - Cile 17
CZ - Repubblica Ceca 17
DZ - Algeria 16
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
IL - Israele 15
CH - Svizzera 14
JM - Giamaica 14
NP - Nepal 14
EG - Egitto 13
LB - Libano 13
MY - Malesia 12
GE - Georgia 10
KR - Corea 10
LV - Lettonia 9
AL - Albania 8
HN - Honduras 8
KZ - Kazakistan 8
PH - Filippine 8
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
RO - Romania 7
SY - Repubblica araba siriana 7
BH - Bahrain 6
EU - Europa 6
LT - Lituania 6
PA - Panama 6
AU - Australia 5
BA - Bosnia-Erzegovina 5
EE - Estonia 5
ET - Etiopia 5
GR - Grecia 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NG - Nigeria 4
OM - Oman 4
PT - Portogallo 4
QA - Qatar 4
BY - Bielorussia 3
DK - Danimarca 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
MK - Macedonia 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
Totale 36.713
Salva come PNG Salva come JPEG
Città #
Moscow 2.194
Dublin 1.868
Singapore 1.616
Jacksonville 1.433
Ashburn 1.430
Dallas 1.287
Chandler 1.266
Nyköping 761
Hong Kong 724
Beijing 713
San Jose 411
Princeton 339
Cambridge 330
The Dalles 328
Lauterbourg 303
Dearborn 297
Los Angeles 273
Des Moines 270
Medford 256
Boardman 223
Munich 211
Ann Arbor 195
São Paulo 195
New York 168
Buffalo 153
Bremen 142
Ho Chi Minh City 133
Messina 132
Tianjin 105
Jinan 96
Hanoi 90
Woodbridge 89
San Mateo 87
Shenyang 85
Wilmington 85
Redondo Beach 81
Lancaster 77
Helsinki 75
Warsaw 75
Rio de Janeiro 74
Pune 63
Belo Horizonte 56
Frankfurt am Main 56
Orem 55
Curitiba 52
Nanjing 51
Brussels 49
Turku 48
Guangzhou 47
Tokyo 43
Hebei 41
Zhengzhou 41
Houston 39
Vienna 39
Brooklyn 38
Chennai 37
Council Bluffs 37
Porto Alegre 36
Tashkent 36
Ningbo 35
Hangzhou 33
Johannesburg 33
Montreal 33
Chicago 32
Boston 31
Brasília 31
Atlanta 30
Düsseldorf 30
Haikou 30
Norwalk 30
Quito 29
Santa Clara 29
Abidjan 28
Salvador 28
San Francisco 27
Nairobi 26
Rome 26
Seattle 25
Baghdad 24
Campinas 24
Goiânia 24
Manchester 24
Shanghai 24
Taizhou 24
Augusta 22
Milan 22
Montevideo 22
Nanchang 22
Nuremberg 22
Denver 21
Guarulhos 21
Shenzhen 21
Ankara 20
Da Nang 20
Guayaquil 20
Manaus 20
Amsterdam 19
Stockholm 19
Baku 18
Haiphong 18
Totale 20.571
Salva come PNG Salva come JPEG
Nome #
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 315
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 290
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 264
A DECREASED BRAIN-STEM CONTENT OF GABA MEDIATES HYPERINSULINEMIA IN OBESE ZUCKER RATS 242
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 231
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 229
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 215
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 211
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 199
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 197
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 196
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 196
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 195
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 193
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse 192
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 192
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 187
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 183
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 183
Secrezione insulinica e tolleranza glucidica in dislipidemici e loro modificazioni dopo trattamento ipolipemizzante. 181
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 180
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 180
Cardiovascular effects of raloxifene hydrochloride 177
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 176
Altered platetel magnesium and urinary soluble form of intercellular adhesion molecule concentrations in insulin dependent diabetes mellitus patients with microalbuminuria 176
Autoantibodies against cytokeratin 19 in patients with type 1 diabetes mellitus 172
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 167
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 166
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. 165
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 164
[Circadian variations of T3 and T4 in euthyroid subjects]. 164
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 163
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. 163
SERUM ACTIVITY OF BETA- N-ACETYLGLUCOSAMINIDASE IN OBESE HYPERINSULINEMIC SUBJECTS. 161
Anti-p53 autoantibodies in patients with IDDM 159
Age and metabolic control influence lens opacity in IDDM patients 159
Calcio e secrezione endocrina pancreatica Nota III. Efffetti di una infusione di calcio sulla secrezione glucagonica da ipoglicemia insulinica. 158
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 158
[beta-Adrenergic blockade and circadian variations of IRI]. 158
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 158
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 158
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 156
Correlates of total homocysteine plasma concentration in type 2 diabetes 155
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics]. 155
Age and metabolic control influence lens opacity in IDDM patients. 154
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 154
[Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics]. 154
SERUM URINARY ACTIVITIES OF b-N-ACETYLGLUCOSAMINIDASE AND b-GLUCURONIDASE IN DIABETIC PATIENTS. 153
[Blood cortisol changes due to insulin hypoglycemia and serum renin dynamics in the cold pressor test in normal and hypertensive subjects]. 153
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 153
[Circadian variations of immunoreactive insulin and beta-receptors blockade]. 152
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 152
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 152
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 149
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
[Behavior of plasma renin activity (PRA) after administration of a calcium antagonist]. 149
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 149
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 148
ADULT HEIGHT EXCEEDING TARGET HEIGHT IN A PATIENT WITH CONGENITAL PANHYPOPITUITARISM DIAGNOSED AFTER THE AGE OF 25 YEARS 148
Valutazione delle apoproteine A e B, delle lipoproteine e dei lipidi plasmatici durante trattamento con benzafribato in varie forme di iperlipoproteinemia. 148
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 148
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 147
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 147
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 146
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 143
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 143
A multicenter study on the prevalence of diabetic neuropathy in Italy 142
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 142
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients]. 142
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 142
[P.R.A. and cold pressor test following beta receptor block during arterial hypertensive syndromes]. 141
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 140
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 140
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 140
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 139
Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major 138
[Circadian variations in blood cortisol and the rapid inhibition test with dexamethasone in primary and secondary hypertension patients]. 137
[Circadian variations in glycemia and IRI in normal subjects, young and adult diabetics and in obese subjects]. 137
[Fibrinolysis and the cold pressor test]. 136
[Hypertriglyceridemia, IRI and platelet aggregation]. 136
beta-Adrenergic blockade and circadian variations of IRI 136
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 135
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 134
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 134
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 134
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 134
Glucose tolerance,insulin secretion and peripheral sensitivity in thalassemia major 133
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 133
[Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation]. 133
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 133
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 133
[Thyroid hormones and adrenergic stimulation. II. TSH and reverse T3 behavior]. 132
[Behavior of plasma renin activity (PRA) after administration of DOCA in normal subjects]. 131
Plasma insulin and glucose time courses following biliary pancreatic diversion: evaluation of two different ways of glucose loading. 130
Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia 129
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 129
Totale 16.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021446 0 0 0 0 0 0 0 0 0 156 209 81
2021/20222.111 18 269 30 85 53 7 149 88 44 447 265 656
2022/20235.360 428 363 217 400 523 522 38 340 2.288 32 163 46
2023/20241.246 89 218 90 116 93 303 21 70 18 34 12 182
2024/20255.890 72 50 102 319 287 168 129 1.388 1.598 325 496 956
2025/202616.217 761 1.152 1.371 1.295 1.328 3.856 1.978 1.979 1.979 518 0 0
Totale 36.967